[{"NetIncomeLoss_1_Q2_USD":-28072000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":79304627.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":11618000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":623000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":15227000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":59094000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":188791000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":12610000.0,"AssetsCurrent_0_Q2_USD":540225000.0,"ContractWithCustomerAssetNetNoncurrent_0_Q2_USD":13972000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":77595795.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":25800000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2548000.0,"AccruedSalariesCurrent_0_Q2_USD":4371000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":9741000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":601000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":481000.0,"CommonStockSharesIssued_0_Q2_shares":86802162.0,"Assets_0_Q2_USD":653594000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":68229000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":189054000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":25800000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7503000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":15232000.0,"OperatingLeaseLiability_0_Q2_USD":81038000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":62753000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2159000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":55947000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":26669000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":195101000.0,"OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_0_Q2_USD":0.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":15200000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1607000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":635000.0,"AccountsReceivableNetCurrent_0_Q2_USD":1717000.0,"CommonStockValue_0_Q2_USD":87000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":4804000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":13378000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1453000.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":50000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":276998000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"OtherAssetsNoncurrent_0_Q2_USD":9000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":433074000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":78683000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":60800000.0,"CapitalizedContractCostAmortization_2_Q2_USD":644000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":481000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":89111000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-27591000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":12988000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"VariableLeaseCost_1_Q2_USD":415000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-445137000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":348260000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1717000.0,"CommonStockSharesOutstanding_0_Q2_shares":86802162.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"RestrictedCashNoncurrent_0_Q2_USD":15227000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7236000.0,"StraightLineRentAdjustments_2_Q2_USD":5910000.0,"StraightLineRentAdjustments_1_Q2_USD":2972000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":12168000.0,"VariableLeaseCost_2_Q2_USD":1025000.0,"LiabilitiesCurrent_0_Q2_USD":45322000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5099000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3570000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":3149000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.084,"ShortTermLeaseCost_2_Q2_USD":700000.0,"ShortTermLeaseCost_1_Q2_USD":200000.0,"AdditionalPaidInCapital_0_Q2_USD":918535000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":448301000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":172000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":15932000.0,"NetIncomeLoss_2_Q2_USD":-61592000.0,"AccountsPayableCurrent_0_Q2_USD":13563000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-518000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1706000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":54688000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":7980000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":5465000.0,"OperatingIncomeLoss_2_Q2_USD":-63199000.0,"OperatingIncomeLoss_1_Q2_USD":-28707000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q2_USD":0.0,"InvestmentIncomeInterest_2_Q2_USD":1607000.0,"InvestmentIncomeInterest_1_Q2_USD":635000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":14626000.0,"PreferredStockValue_0_Q2_USD":3000.0,"OperatingLeaseCost_2_Q2_USD":6935000.0,"OperatingLeaseCost_1_Q2_USD":3387000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":653594000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":14149000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":7236000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2355000.0,"OperatingExpenses_2_Q2_USD":71179000.0,"OperatingExpenses_1_Q2_USD":34172000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":48226000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.79,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.35,"ProfitLoss_2_Q2_USD":-61592000.0,"StockholdersEquity_0_Q2_USD":474111000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":12788000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-60991000.0,"Ticker":"FATE","CIK":"1434316","name":"FATE THERAPEUTICS INC","OfficialName":"Fate Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3545646272.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]